Alnylam Pharmaceuticals (ALNY) PT Lowered to $211 at UBS
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $248.68 +0.43%
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
UBS analyst Esther Rajavelu lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $211.00 (from $215.00) while maintaining a Buy rating.
You May Also Be Interested In
- Alnylam Pharmaceuticals (ALNY) PT Raised to $248 at JPMorgan
- HCL Technologies (HCLT:IN) PT Raised to INR1,510 at JPMorgan
- Tech Mahindra Ltd. (TECHM:IN) PT Raised to INR1,200 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
